TipRanks
Go Ultimate55% OFF

Illumina (ILMN) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

ILMN Analyst Ratings

Moderate Buy
18Ratings
9Buy6Hold3Sell
Based on 18 analysts giving stock ratings to Illumina in the past 3 months

ILMN Stock 12 Month Forecast

MXN 4,939.18â–¼(-8.43% Downside)
Based on 18 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is MXN 4,939.18 with a high forecast of MXN 5,825.53 and a low forecast of MXN 3,476.53. The average price target represents a -8.43% change from the last price of MXN 5,393.90.
Highest Price TargetMXN 5,825.53Average Price TargetMXN 4,939.18Lowest Price TargetMXN 3,476.53

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:ILMN
Price TargetFollowArticle
CitiMXN 2,123.50→MXN 3,946.33sell-26.84%DownsideReiterated11/02/26
BarclaysMXN 3,758.41sell-30.32%DownsideReiterated10/30/26
Stifel NicolausMXN 4,228.21→MXN 5,637.61buy4.52%UpsideReiterated10/30/26
Piper SandlerMXN 5,731.57buy6.26%UpsideReiterated10/30/26
Canaccord GenuityMXN 5,637.61hold4.52%UpsideReiterated10/30/26
Evercore ISIMXN 5,449.69→MXN 5,167.81buy-4.19%DownsideReiterated10/30/26
J.P. MorganMXN 6,013.46→MXN 5,637.61buy4.52%UpsideReiterated10/30/26
Bank of America SecuritiesMXN 3,157.06→MXN 3,758.41sell-30.32%DownsideReiterated10/29/26
RBC CapitalMXN 5,825.53buy8.00%UpsideReiterated10/29/26
GuggenheimMXN 5,731.57buy6.26%UpsideReiterated10/29/26
Robert W. Baird Analyst forecast on MX:ILMNUnknown AnalystNot RankedRobert W. BairdMXN 5,374.53hold-0.36%DownsideReiterated10/27/26
StephensMXN 4,002.71→MXN 5,167.81hold-4.19%DownsideDowngraded10/23/26
BernsteinMXN 4,040.29hold-25.10%DownsideAssigned10/19/26
TD CowenMXN 3,946.33→MXN 5,073.85hold-5.93%DownsideReiterated10/13/26
Leerink PartnersMXN 4,134.25→MXN 5,637.61buy4.52%UpsideReiterated09/29/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months
Success Rate10/17 ratings generated profit
59%
Average Return
-1.31%

Copying Patrick B Donnelly's trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of -1.31% per trade.

1 Year
Success Rate26/33 ratings generated profit
79%
Average Return
+18.15%

Copying Doug Schenkel's trades and holding each position for 1 Year would result in 78.79% of your transactions generating a profit, with an average return of +18.15% per trade.

2 Years
Success Rate24/33 ratings generated profit
73%
Average Return
+47.29%

Copying Doug Schenkel's trades and holding each position for 2 Years would result in 72.73% of your transactions generating a profit, with an average return of +47.29% per trade.

ILMN Analyst Recommendation Trends

010203040Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for ILMN
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy1615171915
Hold9911119
Sell75476
Strong Sell00000
total3229323730

In the current month, ILMN has received 15 Buy Ratings, 9 Hold Ratings, and 6 Sell Ratings. ILMN average Analyst price target in the past 3 months is 4,939.18.

ILMN Financial Forecast

MXN 20MXN 22.5MXN 25MXN 27.5MXN 30Q1 2026Q3 2026Q4 2026
HighMXN 29.33
ConsensusMXN 28.77
LowMXN 28.38

ILMN Earnings Forecast

Next quarter’s earnings estimate for ILMN is MXN 28.77 with a range of MXN 28.38 to MXN 29.33. The previous quarter’s EPS was MXN 27.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

MXN 20.5BMXN 21.2BMXN 21.8BMXN 22.5BMXN 23.2BQ1 2026Q3 2026Q4 2026
HighMXN 23.2B
ConsensusMXN 23B
LowMXN 22.9B

ILMN Sales Forecast

Next quarter’s sales forecast for ILMN is MXN 23.03B with a range of MXN 22.85B to MXN 23.19B. The previous quarter’s sales results were MXN 21.24B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ILMN Stock Forecast FAQ

What is MX:ILMN’s average 12-month price target, according to analysts?
Based on analyst ratings, Illumina’s 12-month average price target is Mex$4,939.18.
What is MX:ILMN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MX:ILMN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Illumina a Buy, Sell or Hold?
Illumina has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 6 hold ratings and 3 sell ratings.
What is Illumina’s share price target?
The average share price target for Illumina is Mex$4,939.18. This is based on 18 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$5,825.53, and the lowest forecast is Mex$3,476.53. The average share price target represents a 8.43% decrease from the current price of Mex$5,393.9.
What do analysts say about Illumina?
Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Street analysts.
How can I buy shares of Illumina?
To buy shares of MX:ILMN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.